6978 — Immunotech Biopharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Immunotech Biopharm, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	845	353	79.5	178	63.1
Net Total Receivables	0	—	—	—	0.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	884	412	118	214	87.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	154	427	527	501	452
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,210	1,098	879	846	564
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	31.6	180	208	203	430
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	82.7	275	371	673	577
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,128	822	508	174	-13.3
Total Liabilities & Shareholders' Equity	1,210	1,098	879	846	564
Total Common Shares Outstanding